<DOC>
	<DOCNO>NCT01192919</DOCNO>
	<brief_summary>Overview treatment reality patient bronchial carcinoma require systemic treatment treat office-based oncologist Germany .</brief_summary>
	<brief_title>Tumour Registry Lung Cancer ( TLK )</brief_title>
	<detailed_description>The TLK prospective , longitudinal , nation wide cohort study collect data treatment reality patient NSCLC SCLC . At inclusion , data patient characteristic , comorbidities , tumor characteristic , biomarker test previous treatment collect . During course observation data systemic treatment , radiotherapy , surgery , outcome document . Patients follow death maximum 3 year .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>histologically confirm Small Cell Lung Cancer ( SCLC ) , Non Small Lung Cancer ( NSCLC ) neuroendocrine tumor receive therapy write informed consent start neoadjuvant , adjuvant firstline therapy longer 4 week informed consent patient receive systemic therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>bronchial carcinoma</keyword>
	<keyword>registry</keyword>
	<keyword>real life treatment</keyword>
	<keyword>cohort study</keyword>
	<keyword>NSCLC</keyword>
	<keyword>SCLC</keyword>
	<keyword>Germany</keyword>
</DOC>